Revenue

Following a 22% stock plunge after a bleak 2026 forecast, Syensqo's top shareholder, Solvac, publicly vows support and close monitoring of the situation.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

Motorola's new Razr Fold boasts a top-tier camera, massive battery, and 7-year support. Can it dethrone Samsung and redefine the foldable market?

Yeahka is one of only two mainland Chinese firms in its category to join S&P's elite 2026 Sustainability Yearbook, signaling a new era for ESG.

The Regina-based food giant aims to raise massive capital to pay down debt and accelerate its global expansion in the booming plant-based food market.

Following high-grade discoveries, North Arrow launches a $2.3M campaign using advanced tech to unlock a potentially vast gold district in Botswana.

The FDA has greenlit Ascendis Pharma's once-weekly YUVIWEL for achondroplasia, a major step for patients that also carries significant business implications.

Secure endpoint leader IGEL appoints veteran Ash Chowdappa as CPO, signaling a major push in product innovation amid rapid global expansion and hiring.

With its new AI thriller, muVpix is betting on 'engineered storytelling' to finally crack the vertical video code that doomed giants like Quibi.

Canada’s ambitious high-speed rail plan is facing fierce opposition from farmers who say the project threatens their land, livelihood, and food security.

As Prime Drink Group faces heavy losses, the appointment of water industry expert Germain Turpin as interim CEO signals a strategic pivot to its core assets.

A $4.4 million inventory write-down plunges the world's first private cord blood bank into the red, raising questions about its public banking model.

Silvano Fashion Group's 2025 results reveal a sharp 39.5% drop in operating profit and shrinking margins, raising concerns despite a stronger balance sheet.

Healthpeak Properties is launching a new senior housing REIT, Janus Living. What does this strategic pivot mean for investors and the real estate market?

In a radical pivot, diagnostics firm OpGen has become CapForce, an AI-powered investment bank targeting a $10B niche. Can it trade microbes for money?

The industrial fluids leader declared a steady dividend, reflecting financial discipline and confidence in its long-term strategy despite market headwinds.

Chart Industries reports strong 2025 orders driven by new energy markets, offsetting a dip in Q4, as it prepares for its acquisition by Baker Hughes.

Digital pen inventor Anoto reports shrinking sales but better margins, leaning on a high-stakes loan to fuel its strategic reboot in a competitive market.

AMTD Digital reports explosive growth, but a closer look reveals a complex strategy involving media, SPACs, and a recent change in auditors.

With key investor conferences looming, Asana is set to showcase its AI strategy. Can it convince Wall Street its vision will drive profit and beat rivals?